MSK Ventures
Profile and leaders
MSK Ventures is the corporate venture arm of Memorial Sloan Kettering Cancer Center, a healthcare company. It was founded in 2026 and is based in New York, United States. Sectors it names: biotech and life sciences, artificial intelligence.
Every figure links to its source
Where it invests and who leads it
Geography
- Headquarters
- New York, United States
- Offices
LeadersS3S1
- Whitney SniderInaugural Managing PartnerFind on LinkedInFirm page
- Anaeze Offodile IIExecutive Sponsor; MSK Executive Vice President and Chief Strategy OfficerFind on LinkedInFirm page
Key facts
| Fact | Value | Status | Source |
|---|---|---|---|
| Parent company | Memorial Sloan Kettering Cancer Center | Single source | S1 |
| Parent industry | Healthcare and life sciences | Single source | S1 |
| Founded | 2026 | Single source | S1 |
| Headquarters | New York, United States | Reported by Wikipedia: Memorial Sloan Kettering Cancer Center (1275 York Avenue | S4 |
| Status | Active | Single source | S1 |
| Capital source | Parent and outside investors | Single source | S1 |
For founders
| Item | What the firm says | Source |
|---|---|---|
| Beyond capital | Access to MSK science, intellectual property and its Commercialization Ecosystem programs | S1 |
History
- MSK announced MSK Ventures and named Whitney Snider inaugural Managing Partner in January 2026S2
Official pages
Read the firm's own pages for current information.
- Website www.mskcc.org/commercialization/msk-ventures
Sources
Disclaimer and corrections
Not affiliated. This page is not affiliated with, endorsed by or sponsored by MSK Ventures or any company named on it. Names and trademarks belong to their owners. Informational only. This is a public-source reference. It is not investment, legal or tax advice and not an offer or solicitation. Sources. Each figure names its source. Figures may have changed. Please read the firm's official pages, linked above. Corrections and takedown. To report an error or ask for a change or removal, use the correction form or email Richard@CorporateVentureCapital.com.
Spotted a mistake? Report a correction.